In general, people around the world are eating better and living longer, but they are also moving less. This is contributing to the rise of diabetes, a condition that affects 422 million people and is fast becoming a major problem, especially in poor countries.
Two factors are critical for the successful treatment of diabetes patients. First is a correct diagnosis of the type of the disease, and second is the administration of the appropriate drugs.
A misdiagnosis and, consequently, the wrong treatment can cause many problems.
“If you label someone who actually has type 2 diabetes as type 1, they'll be left on insulin for the rest of their life when they don't need it," said Dr. Richard Oram of the U.K. National Institute for Health Research. "Even worse, if someone with type 1 diabetes is mislabeled as having type 2 diabetes, then they may not be treated with the insulin they need, and they may suffer life-threatening complications.”
A new, less expensive test, developed at the University of Exeter Medical School, measures 30 genetic variants in the patient’s DNA and calculates the risk for type 1 or type 2. Individual diagnoses can be completed with a commonly used test for antibodies.
Scientists are now trying to develop an even simpler DNA-based test that could be done with a smartphone app.
No more injections?
In the meantime, researchers in South Korea are developing a nanotechnology-based adhesive strip that takes away pain and stress of daily injections for diabetes patients.
“The device is a patch type that enables [diabetics] to monitor blood sugar levels via sweat without taking blood samples and injections, as well as to control glucose levels by injecting medication,” said Kim Dae-hyeong, a professor in the School of Chemical and Biological Engineering at Seoul National University.
The patch is studded with microneedles that painlessly enter subcutaneous tissue. When the connected chip senses that the level of glucose has risen above normal, a small heating element dissolves medication and releases it into the bloodstream.
Tests done on lab mice were promising, so scientists hope they will soon start testing the patch on humans. In this phase, experiments are still expensive, but scientists say the price will drop once it the patch is ready for mass production.
Vocabulary
misdiagnosis: 误诊,漏诊
2015考研英语阅读芝加哥财政预算
2015考研英语阅读中国珠宝商
2015考研英语阅读柬埔寨乱砍滥伐
2015考研英语阅读共和党的预算草案
2015考研英语阅读暴风雪袭击芝加哥
2015考研英语阅读繁文缛节该省省了
2015考研英语阅读创业国度的未来如何
2015考研英语阅读欧洲的问题不在于货币
2015考研英语阅读谎言诱惑下的合作
2015考研英语阅读古斯塔夫莱昂哈特
2015考研英语阅读平等保护同性恋婚姻
2015考研英语阅读雪佛龙与巴西石油业
2015考研英语阅读对富人征税弊端多
2015考研英语阅读乔布斯传
2015考研英语阅读技术与公民自由
2015考研英语阅读日本能源问题
2015考研英语阅读酿造商的并购
2015考研英语阅读美国煤炭的燃眉之急
2015考研英语阅读食品荒漠
2015考研英语阅读美众议院的茶党成员
2015考研英语阅读选民身份认定
2015考研英语阅读纽约州长安德鲁科莫
2015考研英语阅读鲍比一举夺魁
2015考研英语阅读侵权法改革
2015考研英语阅读学校改革的佼佼者
2015考研英语阅读更小却更美丽
2015考研英语阅读维基百科集资
2015考研英语阅读梦想之地
2015考研英语阅读传递快乐的使者
2015考研英语阅读百事应该拆分吗
不限 |
英语教案 |
英语课件 |
英语试题 |
不限 |
不限 |
上册 |
下册 |
不限 |